心臟再同步化治療市場規模、份額和趨勢分析報告:按產品(CRT-除顫器、CRT-起搏器)、最終用戶(醫院、心臟中心、其他)、地區、分部預測,2023 ~ 2030 年
市場調查報告書
商品編碼
1171050

心臟再同步化治療市場規模、份額和趨勢分析報告:按產品(CRT-除顫器、CRT-起搏器)、最終用戶(醫院、心臟中心、其他)、地區、分部預測,2023 ~ 2030 年

Cardiac Resynchronization Therapy Market Size, Share & Trends Analysis Report By Product (CRT-Defibrillator, CRT-Pacemaker), By End-use (Hospitals, Cardiac Centers, Others), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

心臟再同步化治療市場的增長和趨勢

根據 Grand View Research 的一份新報告,到 2030 年,全球心臟再同步化治療市場預計將達到 62.3 億美元。從 2023 年到 2030 年,該市場預計將以 4.8% 的複合年增長率增長。推動市場增長的主要因素包括主要參與者擴大計劃、提高產品進步以及增加最終用戶對產品的採用。

CRT 市場受到 COVID-19 大流行的嚴重影響。COVID-19 對市場的主要影響包括需求放緩、銷售下降以及由於運營障礙和選擇性行動取消而導致的供應鏈中斷。例如,心律管理設備業務的領導者雅培(Abbott)報告其心血管業務在 2020 年的盈利增長較低。波士頓科學報告稱,2020 年所有地區的銷售額都將下降。2021年第三季度,公司銷售額逐步恢復,心律管理業務佔總銷售額15億美元。

此外,COVID-19對美敦力截至 2020 年 4 月 24 日的第四季度業績產生了負面影響。使用美敦力設備推遲選擇性和半選擇性治療對公司產生了影響。人們不願採取 COVID-19 以外的緊急措施將影響公司的新興產品線。到 2021 年,公司的銷售額將恢復正增長。在截至 2021 年 10 月的六個月中,該公司心臟和節律管理產品組合的銷售額同比增長 11%。

市場主要參與者不斷增加的產品進步和舉措預計將推動未來幾年的市場增長。例如,2020 年 2 月,Medtronic 的心臟再同步治療除顫器 (CRT-D) 獲得了 CE 標誌批准,該產品結合了 AdaptivCRT 和 EffectiveCRT 算法等智能功能。同樣,在 2020 年 7 月,Abbott獲得了美國 FDA 批准的支持藍牙的心臟再同步治療除顫器 (CRT-D) 設備。

心臟再同步化治療市場報告要點

2022 年心臟再同步化治療市場價值 42.6 億美元,預計在預測期內以 4.8% 的複合年增長率增長

快速的技術進步是推動市場增長的主要趨勢之一。採用久坐不動的生活方式和不斷增加的老年人口以及心血管疾病患病率的上升也推動了市場增長。

CRT-D 在 2022 年佔據了產品的市場份額。這是由於這些設備的採用率高、應用範圍廣以及心血管疾病患病率上升。

在 2022 年的市場中,CRT-P 將佔據顯著份額,預計在預測期內將以最快的速度增長。這是由於全球範圍內不斷擴大的適應症和心力衰竭的高患病率。

2022年,醫院板塊佔據最大市場份額,超過52.08%。這些中心被認為是診斷後放置 CRT 設備的主要地點。

由於其完善的醫療體系和人均醫療支出,預計到 2022 年北美將佔據最大的市場份額,超過 49.9%,從而推動預測期內的市場增長。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫:
    • GVR內部數據庫
    • 次要信息
    • 初步調查:
    • 初步調查詳情
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
  • 二級信息列表
  • 報告目的

第二章執行摘要

  • 2018-2030 年心臟再同步化治療 (CRT) 市場展望(百萬美元)
  • 2022 年心臟再同步化治療 (CRT) 市場概況

3. 心臟再同步化治療 (CRT) 市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 輔助市場展望
  • 繪製滲透率和增長前景
  • 心臟再同步化治療 (CRT) 市場動態
    • 市場驅動力分析
      • 心血管疾病患病率增加
      • 技術進步
      • 久坐不動的生活方式的興起
      • 老年人口不斷增長
    • 市場約束因素分析
      • 產品召回
      • 設備成本高
  • 監管框架
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 心臟再同步化治療 (CRT) 市場分析工具
    • 行業分析 - 搬運工
      • 供應商議價能力:低
      • 買家議價能力:低
      • 替代威脅:高
      • 新進入者的威脅:低
      • 競爭對手之間的敵意:中等
    • 心臟再同步化治療 (CRT) - SWOT 分析,按因素(政治和法律、經濟、技術)
      • 政治和法律環境
      • 金融情況
      • 社會局勢
      • 科技景觀
  • 美國心臟再同步化治療程序代碼表
    • 初始、升級和更換 CRT 系統植入物的 CPT 代碼列表
    • 初始、升級和更換 CRT 系統植入物的 ICD-10-PCS 代碼
  • 全球心臟再同步化治療 (CRT) 市場,Asp,2018-2030(美元)按地區
    • 全球 CRT 除顫器,Asp,按地區 2018-2030(美元)
    • 全球 CRT 起搏器,Asp,按地區 2018-2030(美元)
  • 2018-2030 年按地區分列的全球心臟再同步化治療 (CRT) 市場,單位體積(美元)
    • 全球 CRT 除顫器,單位,按地區,2018-2030(美元)
    • 2018-2030 年按地區分列的全球 CRT 起搏器(美元)
  • COVID-19 影響分析
    • COVID-19 的影響和未來情景
    • 對市場參與者的影響
      • 競爭因素和戰略

第 4 章心臟再同步化治療 (CRT) 市場:產品估計和趨勢分析

  • 2022 年和 2030 年產品市場份額分析
  • 產品儀表板
  • CRT顯示器
  • CRT-P

5 心臟再同步化治療 (CRT) 市場:最終用途估計和趨勢分析

  • 2022 年和 2030 年最終用途市場份額分析
  • 最終用途儀表板
  • 醫院
  • 心臟中心
  • 其他

6 心臟再同步治療 (CRT) 市場:按地區、副產品、最終用途的估計和趨勢分析

  • 區域市場快照
  • 2022 年和 2030 年區域市場份額分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第 7 章 競爭格局

  • 公司簡介
    • ABBOTT
      • 公司簡介
      • 產品基準
      • 財務績效
      • 戰略舉措
    • BOSTON SCIENTIFIC CORPORATION
      • 公司簡介
      • 產品基準
      • 財務績效
      • 戰略舉措
    • MEDTRONIC
      • 公司簡介
      • 產品基準
      • 財務績效
      • 戰略舉措
    • BIOTRONIK SE & CO. KG
      • 公司簡介
      • 產品基準
      • 財務績效
      • 戰略舉措
    • MICROPORT SCIENTIFIC CORPORATION
      • 公司簡介
      • 產品基準
      • 財務績效
      • 戰略舉措
    • Livanova plc.
      • 公司簡介
      • 產品基準
      • 財務績效
      • 戰略舉措
  • 市場參與的分類
    • 公司市場分析
  • 主要交易和戰略聯盟分析
Product Code: GVR-1-68038-347-8

Cardiac Resynchronization Therapy Market Growth & Trends:

The global cardiac resynchronization therapy market size is anticipated to reach USD 6.23 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 4.8% from 2023 to 2030. The key factors driving the market growth include growing initiatives by key companies, rising product advancements, and increasing product adoption by end users

The CRT market was significantly impacted by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include demand slowdown, fall in sales, and supply chain disruption due to the cancellation of operational hurdles and elective procedures. For instance, Abbott, one of the major players in the cardiac rhythm management device business, reported a decline in revenue growth of the cardiovascular business in 2020. Boston Scientific has reported a decline in sales across all regions in 2020. By Q3 2021, the company's sales recovered gradually with the cardiac rhythm management segment accounting for USD 1.5 billion in total revenue.

Furthermore, COVID-19 had a negative impact on Medtronic's fourth-quarter financial performance, which ended on April 24, 2020. Postponed elective and semi-elective treatments using Medtronic devices had an impact on the corporation. People's reluctance to undertake non-COVID-19 emergency procedures has an impact on the company's emerging product lines. By 2021, the company's sales had returned to positive territory. Its cardiac & rhythm management portfolio revenues increased by 11% year on year for the six months ending in October 2021.

Increasing product advancements and initiatives by key market players are expected to propel market growth in the coming years. For instance, in February 2020, Medtronic received the CE mark clearance for its cardiac resynchronization therapy defibrillators (CRT-Ds) combined with smart features such as AdaptivCRT and EffectivCRT algorithms. Similarly, in July 2020, Abbott received approval from the US FDA for its cardiac resynchronization therapy defibrillator (CRT-D) devices equipped with Bluetooth features.

Cardiac Resynchronization Therapy Market Report Highlights:

  • The Cardiac Resynchronization Therapy market was valued at USD 4.26 billion in 2022 and is expected to grow at a CAGR of 4.8% during the forecast period
  • Rapid technological advancements are one of the key trends escalating market growth. The adoption of a sedentary lifestyle, the growing geriatric population along with the increasing prevalence of cardiovascular diseases is also stimulating the growth of the market
  • CRT-D segment dominated the market by product in 2022, owing to the high adoption of these devices, wider applications, and growing prevalence of cardiovascular diseases
  • CRT-P held a notable share of the market in 2022 and is projected to grow at the fastest rate over the forecast period. This is owing to growing indications and the high prevalence of heart failure across the globe
  • The hospitals' segment held the largest market share of over 52.08% in 2022, as these centers are the main point of care for CRT device installation after diagnosis
  • North America held the largest market share of over 49.9% in 2022, owing to the well-established healthcare system, and per capita, healthcare spending in this region is expected to fuel the market growth over the forecast period

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List Of Secondary Sources
  • 1.8 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Cardiac Resynchronization Therapy (CRT) Market Outlook, 2018 - 2030 (USD Million)
  • 2.2 Cardiac Resynchronization Therapy (CRT) Market Summary, 2022

Chapter 3 Cardiac Resynchronization Therapy (CRT) Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Cardiac Resynchronization Therapy (CRT) Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Increasing Prevalence Of Cardiovascular Diseases
      • 3.3.1.2 Technological Advancements
      • 3.3.1.3 Rising Sedentary Lifestyle
      • 3.3.1.4 Increasing Geriatric Population
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Product Recall
      • 3.3.2.2 High Cost Of Device
  • 3.4 Regulatory Framework
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 APAC
    • 3.4.4 LATAM
    • 3.4.5 MEA
  • 3.5 Cardiac Resynchronization Therapy (CRT) Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's
      • 3.5.1.1 Bargaining Power Of Suppliers: Low
      • 3.5.1.2 Bargaining Power Of Buyers: Low
      • 3.5.1.3 Threat Of Substitutes: High
      • 3.5.1.4 Threat Of New Entrants: Low
      • 3.5.1.5 Competitive Rivalry: Moderate
    • 3.5.2 Cardiac Resynchronization Therapy (CRT)- Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
      • 3.5.2.1 Political & Legal Landscape
      • 3.5.2.2 Economic Landscape
      • 3.5.2.3 Social Landscape
      • 3.5.2.4 Technology Landscape
  • 3.6 U.S. Cardiac Resynchronization Therapy Procedure Code List
    • 3.6.1 CPT Codes List For Initial, Upgrade, And Replacement CRT System Implant
    • 3.6.2 ICD-10-Pcs Codes For Initial, Upgrade, And Replacement CRT System Implant
  • 3.7 Global Cardiac Resynchronization Therapy (CRT) Market, Asp, By Region 2018 - 2030 (USD)
    • 3.7.1 Global CRT-Defibrillator, Asp, By Region 2018 - 2030 (USD)
    • 3.7.2 Global CRT-Pacemaker, Asp, By Region 2018 - 2030 (USD)
  • 3.8 Global Cardiac Resynchronization Therapy (CRT) Market, Unit Volume, By Region 2018 - 2030 (USD)
    • 3.8.1 Global CRT-Defibrillator, Unit Volume, By Region 2018 - 2030 (USD)
    • 3.8.2 Global CRT-Pacemaker, Unit Volume, By Region 2018 - 2030 (USD)
  • 3.9 Covid-19 Impact Analysis
    • 3.9.1 Covid-19 Impact And Future Scenario
    • 3.9.2 Impact On Market Players
      • 3.9.2.1 Factors And Strategies, By The Competitor

Chapter 4 Cardiac Resynchronization Therapy (CRT) Market: Product Estimates & Trend Analysis

  • 4.1 Product Market Share Analysis, 2022 & 2030
  • 4.2 Product Dashboard
  • 4.3 CRT-D
    • 4.3.1 CRT-D Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4 CRT-P
    • 4.4.1 CRT-P Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Cardiac Resynchronization Therapy (CRT) Market: End-Use Estimates & Trend Analysis

  • 5.1 End-Use Market Share Analysis, 2022 & 2030
  • 5.2 End-Use Dashboard
  • 5.3 Hospital
    • 5.3.1 Hospital Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Cardiac Centers
    • 5.4.1 Cardiac Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Other End-Users Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Cardiac Resynchronization Therapy (CRT) Market: Regional Estimates & Trend Analysis, By Product, And End-Use

  • 6.1 Regional Market Snapshot
  • 6.2 Region Market Share Analysis, 2022 & 2030
  • 6.3 North America
    • 6.3.1 North America Cardiac Resynchronization Therapy (CRT) Market Estimates And Orecasts, 2018 - 2030 (USD Million)
    • 6.3.2 U.S.
      • 6.3.2.1 U.S. Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Canada
      • 6.3.3.1 Canada Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Europe
    • 6.4.1 Europe Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2 UK
      • 6.4.2.1 UK Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3 Germany
      • 6.4.3.1 Germany Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4 France
      • 6.4.4.1 France Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.5 Italy
      • 6.4.5.1 Italy Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.6 Spain
      • 6.4.6.1 Spain Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5 Asia Pacific
    • 6.5.1 Asia Pacific Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2 JAPAN
      • 6.5.2.1 Japan Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3 China
      • 6.5.3.1 China Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4 India
      • 6.5.4.1 India Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5 Australia
      • 6.5.5.1 Australia Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6 South Korea
      • 6.5.6.1 South Korea Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6 Latin America
    • 6.6.1 Latin America Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2 Mexico
      • 6.6.2.1 Mexico Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3 Brazil
      • 6.6.3.1 Brazil Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4 Argentina
      • 6.6.4.1 Argentina Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7 Middle East & Africa (MEA)
    • 6.7.1 MEA Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2 South Africa
      • 6.7.2.1 South Africa Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3 Saudi Arabia
      • 6.7.3.1 Saudi Arabia Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.4 UAE
      • 6.7.4.1 UAE Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Profiles
    • 7.1.1 ABBOTT
      • 7.1.1.1 Company overview
      • 7.1.1.2 Product benchmarking
      • 7.1.1.3 Financial performance
      • 7.1.1.4 Strategic initiatives
    • 7.1.2 BOSTON SCIENTIFIC CORPORATION
      • 7.1.2.1 Company overview
      • 7.1.2.2 Product benchmarking
      • 7.1.2.3 Financial performance
      • 7.1.2.4 Strategic initiatives
    • 7.1.3 MEDTRONIC
      • 7.1.3.1 Company overview
      • 7.1.3.2 Product benchmarking
      • 7.1.3.3 Financial performance
      • 7.1.3.4 Strategic initiatives
    • 7.1.4 BIOTRONIK SE & CO. KG
      • 7.1.4.1 Company overview
      • 7.1.4.2 Product benchmarking
      • 7.1.4.3 Financial performance
      • 7.1.4.4 Strategic initiatives
    • 7.1.5 MICROPORT SCIENTIFIC CORPORATION
      • 7.1.5.1 Company overview
      • 7.1.5.2 Product benchmarking
      • 7.1.5.3 Financial performance
      • 7.1.5.4 Strategic initiatives
    • 7.1.6 Livanova plc.
      • 7.1.6.1 Company overview
      • 7.1.6.2 Product benchmarking
      • 7.1.9.3 Financial performance
      • 7.1.6.4 Strategic initiatives
  • 7.2 Market Participation Categorization
    • 7.7.1 Company Market Position Analysis
  • 7.3 Major Deals & Strategic Alliances Analysis

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of key companies
  • TABLE 3 U.S. Cardiac Resynchronization Therapy Procedure Code List
  • TABLE 4 CPT Codes list for Initial, Upgrade, and Replacement CRT system implant
  • TABLE 5 ICD-10-PCS Codes for Initial, Upgrade, and Replacement CRT system implant
  • TABLE 6 Global cardiac resynchronization therapy (CRT) Market, ASP, by Region 2018 - 2030 (USD)
  • TABLE 7 Global CRT-Defibrillator, ASP, by Region 2018 - 2030 (USD)
  • TABLE 8 Global CRT-Pacemaker, ASP, by Region 2018 - 2030 (USD)
  • TABLE 9 Global cardiac resynchronization therapy (CRT) Market, Unit Volume, by Region 2018 - 2030 (USD)
  • TABLE 10 Global CRT-Defibrillator, Unit Volume, by Region 2018 - 2030 (USD)
  • TABLE 11 Global CRT-Pacemaker, Unit Volume, by Region 2018 - 2030 (USD)
  • TABLE 12 Impact on Market Players
  • TABLE 13 Global Cardiac Resynchronization Therapy market, by region, 2018 - 2030 (USD Million)
  • TABLE 14 Global Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 15 Global Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 16 North America Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 17 North America Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 18 North America Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 19 U.S. Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 20 U.S. Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 21 Canada Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 22 Canada Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 23 Europe Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 24 Europe Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 25 Europe Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 26 UK Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 27 UK Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Germany Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 29 Germany Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 30 France Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 31 France Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 32 Italy Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 33 Italy Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 34 Spain Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 35 Spain Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 36 Asia Pacific Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 37 Asia Pacific Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 38 Asia Pacific Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 39 China Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 40 China Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 41 Japan Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 42 Japan Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 India Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 44 India Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 45 Australia Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 46 Australia Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 47 South Korea Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 48 South Korea Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 49 Latin America Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 50 Latin America Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 51 Latin America Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD
  • TABLE 52 Brazil Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 53 Brazil Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 54 Mexico Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 55 Mexico Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 56 Argentina Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 57 Argentina Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 58 MEA Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 59 MEA Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 60 MEA Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 61 South Africa Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 62 South Africa Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 63 South Africa Cardiac Resynchronization Therapy market, by application, 2018 - 2030 (USD Million)
  • TABLE 64 Saudi Arabia Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 65 Saudi Arabia Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 66 UAE Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 67 UAE Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Commodity flow analysis
  • FIG. 10 Cardiac Resynchronization Therapy (CRT) market revenue, 2018 - 2030 (USD Million)
  • FIG. 11 Cardiac Resynchronization Therapy (CRT) market snapshot, 2022 (USD Million)
  • FIG. 12 Parent Market Analysis
  • FIG. 13 Ancillary Market Analysis
  • FIG. 14 Penetration & growth prospect mapping by end-use, 2022
  • FIG. 15 Cardiac Resynchronization Therapy (CRT) market dynamics
  • FIG. 16 Cardiac Resynchronization Therapy (CRT) market driver impact
  • FIG. 17 Population aged 65 Years and Above (% of Total Population), 2020
  • FIG. 18 Cardiac Resynchronization Therapy (CRT) market restraint impact
  • FIG. 19 COVID-19 Impact Analysis
  • FIG. 20 Cardiac Resynchronization Therapy (CRT) market: Product movement analysis
  • FIG. 21 Cardiac Resynchronization Therapy (CRT) market: Product dashboard
  • FIG. 22 Global CRT-D market, 2018 - 2030 (USD Million)
  • FIG. 23 Global CRT-P market, 2018 - 2030 (USD Million)
  • FIG. 24 Cardiac Resynchronization Therapy (CRT) market: End-use movement analysis
  • FIG. 25 Cardiac Resynchronization Therapy (CRT) End-use dashboard
  • FIG. 26 Prevalence of Heart, Stroke, and Vascular Disease Among Men Aged 18 & Above, By Age Group, 2018 - 2018
  • FIG. 27 Prevalence of Heart, Stroke, and Vascular Disease Among Women Aged 18 & Above, By Age Group, 2018 - 2018
  • FIG. 28 Global hospital market, 2018 - 2030 (USD Million)
  • FIG. 29 Global cardiac centers market, 2018 - 2030 (USD Million)
  • FIG. 30 Global other end-users market, 2018 - 2030 (USD Million)
  • FIG. 31 Regional marketplace: Key takeaways
  • FIG. 32 Regional outlook, 2022 & 2030
  • FIG. 33 North America Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 34 Leading causes of deaths in the U.S.
  • FIG. 35 U.S. Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 36 Canada Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 37 Europe Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 38 UK Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 39 Germany Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 40 France Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 41 Italy Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 42 CRT Devices Implanted in Spain in 2020
  • FIG. 43 Spain Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 44 Asia Pacific Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 45 Japan Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 46 China Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 47 India Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 48 Australia Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 49 South Korea Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 50 Latin America Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 51 Mexico Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 52 Brazil Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 53 Argentina Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 54 MEA Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 55 South Africa Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 56 Saudi Arabia Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 57 UAE Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 58 Market Participant Categorization
  • FIG. 59 Company market position analysis
  • FIG. 60 Major deals & strategic alliances analysis